Bon Natural Life Ltd

Bon Natural Life Ltd (BON) Stock Analysis

$1.120

+0.002 (+0.20%)At close

Loading chart…
High
1.120
Open
1.092
VWAP
1.11
Volume
10.36K
Mkt Cap
9.09M
Low
1.090
Amount
11.50K
EV/EBITDA, TTM
0.00

Bon Natural Life Ltd is a company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products and lavender essential oil. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

www.bnlus.com

AI analysis of Bon Natural Life Ltd (BON)

Hold

Bon Natural Life Ltd is currently not a strong buy due to its low RSI of 34.467, indicating oversold conditions, and a significant year-to-date change of -34.50%. While the stock has potential upside based on historical patterns projecting a +107.27% change, the current price of 1.12 is near its 52-week low of 0.95, which presents a risk if the stock does not recover. The forward P/E ratio of 2.3491 suggests potential undervaluation, but the negative sentiment and performance trends indicate caution is warranted.

Valuation Metrics

The current forward P/E ratio for Bon Natural Life Ltd (BON) is 2.35, compared to its 5-year average forward P/E of 4.64.

Forward P/E

Fair
5Y Average P/E
4.64
Current P/E
2.35
Overvalued
17.92
Undervalued
-8.64

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
1.54
Current EV/EBITDA
0.00
Overvalued
3.60
Undervalued
-0.51

Forward P/S

Fair
5Y Average P/S
0.32
Current P/S
0.00
Overvalued
0.66
Undervalued
-0.02

Alphio AI Price Scenarios for BON

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BON

$1.68

Scenario price

B

Base

Base · 50%BON

$1.48

Scenario price

B

Bear

Bear · 25%BON

$1.41

Scenario price

Events Timeline

2026-03-31 (ET)

09:10:00

Bon Natural Life Enters Cooperation Agreement with Tigerbone Group

2026-02-19 (ET)

09:10:00

Bon Natural Life Develops Apple Polyphenol Anti-Aging Mask

2025-12-10 (ET)

05:10:00

Bon Natural Life Launches New Product and Signs $12M Collaboration Agreement

2025-11-25 (ET)

09:44:21

Bon Natural Life reveals $26M partnership deal with Beijing Huahai Keyuan

2025-09-09 (ET)

08:33:15

Bon Natural Life Signs $18M Partnership Agreement in China

News

BON FAQ — answered by Alphio AI

Bon Natural Life Ltd is a company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products and lavender essential oil. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries. It operates in the Healthcare sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).

Bon Natural Life Ltd is currently not a strong buy due to its low RSI of 34.467, indicating oversold conditions, and a significant year-to-date change of -34.50%. While the stock has potential upside based on historical patterns projecting a +107.27% change, the current price of 1.12 is near its 52-week low of 0.95, which presents a risk if the stock does not recover. The forward P/E ratio of 2.3491 suggests potential undervaluation, but the negative sentiment and performance trends indicate caution is warranted.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading